Literature DB >> 8731961

The effects of calcium-regulating-hormone on BMC in patients with CRF.

Y M Lü1, H W Xiao, K H Liang.   

Abstract

By means of single photon absorptiometry, bone material content (BMC) on centerbrachium was detected in 34 patients with chronic renal failure (CRF) and 34 sex-age-matched normal controls, and their serum parathyroid hormone (PTH), calcitonin (CT) were also measured by radioimmunoassay. It was found that (1) the mean BMC was obviously lower in patients with CRF than that in the normal controls; (2) PTH and CT obviously rose in patients with CRF; (3) the decrease of BMC was strongly correlated with that of creatinine clearance (Ccr). Furthermore, the more Ccr decreases, the more PTH in blood increases; no relations have been found between BMC and the serum levels of CT. The authors suggest that the development of osteoporosis with CRF is due to the secondary increase of PTH in blood but the effect of increased serum CT levels was not so obvious. Therefore, lowering blood PTH concentrations by parathyroidectomy or renal transplantation may be beneficial to curing osteoporosis of patients with CRF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8731961     DOI: 10.1007/BF02887910

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  6 in total

1.  MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD.

Authors:  J R CAMERON; J SORENSON
Journal:  Science       Date:  1963-10-11       Impact factor: 47.728

2.  Serum bioactive parathyroid hormone in hemodialysis patients.

Authors:  J T McCarthy; G G Klee; P C Kao; S F Hodgson
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

Review 3.  Involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

4.  Elective total parathyroidectomy without autotransplant in end-stage renal disease.

Authors:  M Kaye; P D'Amour; J Henderson
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

5.  Exogenous calcitonin protects against renal bone disease in rats with early renal failure.

Authors:  A D'Angelo; E Bonucci; S Giannini; P Benetollo; M G Lodetti; R Castrignano; L Malvasi; G Maschio
Journal:  Bone Miner       Date:  1987-11

6.  Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism.

Authors:  H Mulder; J Silberbusch; W H Hackeng; G Koorevaar; G J den Ottolander
Journal:  Nephron       Date:  1982       Impact factor: 2.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.